Monte Rosa Therapeutics Inc

NASDAQ:GLUE 4:00:00 PM EDT

6.93

+0.57 (+8.96%)

7:59:16 PM EDT: $6.98 +0.05 (+0.72%)

Market Cap (Intraday)	427.98M
Current PE	17.71
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$7.77 Million
Adjusted EPS	-$0.36

See more estimates

10-Day MA	$5.85
50-Day MA	$5.10
200-Day MA	$5.54

See more pivots

Monte Rosa Therapeutics Inc Stock, NASDAQ:GLUE

321 Harrison Avenue, Suite 900, Boston, Massachusetts 02118

United States of America

Phone: +1.617.949.2643

Number of Employees: 133

http://www.monterosatx.com

Description

Monte Rosa Therapeutics, Inc. operates as a biotechnology company focused on developing precision medicines. The company was founded on November 21, 2019 and is headquartered in Boston, MA.